RELATED CONTENT
NEWS
- YM BioSciences rises on PhI/II results showing promise for JAK1/JAK2 inhibitor for myelofibrosis
- Merck Serono safinamide boomerang 'completely unexpected' by Newron acquisitor BioTie
- S*BIO looks for JAK2 inhibitor partners as it preps for Phase III
- Icahn blasts Amylin over spurned $3.5bn BMS bid
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

